Urovalve Inc.
This article was originally published in Start Up
Executive Summary
Compared with conventional urinary catheters, which require an external collection bag or an intermittent catheter inserted multiple times daily, the Surinate Bladder Management system from Urovalve Inc. could significantly improve the plight of men suffering from acute or chronic urinary retention. The device is designed to empower patients to manage their condition discreetly, thanks to a magnetic valve that passively closes the urethra to prevent urine leakage and can be opened with a handheld external magnet to empty the bladder.
You may also be interested in...
Start-Up Previews (02/2011)
A preview of the emerging health companies profiled in the current issue of Start-Up. This month's profile group, "Emerging MS Treatments: Reading the Gilenya Tea Leaves," includes profiles of Allozyne, GeNeuro, Nuron Biotech and Receptos. Plus these Start-Ups Across Health Care: Intralink-Spine, NinePoint Medical, PanOptica and Urovalve.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.